Oruka Therapeutics, Inc. Common Stock (ORKA) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for ORKA. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR | 9,057,645 | $862M | INCREASED |
| BlackRock | 4,990,181 | $475M | INCREASED |
| VR Adviser | 4,148,428 | $395M | UNCHANGED |
| Fairmount Funds Management | 3,705,262 | $353M | UNCHANGED |
| Capital Group | 3,401,639 | $324M | NEW |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Paul T Quinlan (General Counsel) | EXERCISE | 10,000 | $78K | 2026-09-21 |
| Paul T Quinlan (General Counsel) | SELL | 2,667 | $254K | 2026-09-21 |
| Paul T Quinlan (General Counsel) | SELL | 601 | $57K | 2026-09-21 |
| Paul T Quinlan (General Counsel) | SELL | 3,832 | $358K | 2026-09-21 |
| Paul T Quinlan (General Counsel) | SELL | 2,900 | $268K | 2026-09-21 |
Full institutional holdings, insider history, and congressional trades for Oruka Therapeutics, Inc. Common Stock on SentiSense.